Related Experiment Video
Updated: Jun 12, 2026

11:28
Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
Drug Use and Social Connectivity Related to Hepatitis C Infection Among Rural People Who Use Drugs
Alex Rains1, Ellen Almirol2, William Nicholson3
1Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Journal of Viral Hepatitis
|June 11, 2026
Summary
Rural individuals who use drugs face high hepatitis C virus (HCV) risks. Interventions led by peer champions can improve access to vital risk-mitigation services for this population.
Area of Science:
- Public Health
- Epidemiology
- Social Network Analysis
Background:
- People who use drugs (PWUD) have a significantly higher risk of hepatitis C virus (HCV) infection.
- Access to screening and treatment for HCV is often limited in rural areas due to healthcare shortages.
- Understanding factors associated with HCV positivity in rural PWUD is crucial for developing effective interventions.
Purpose of the Study:
- To investigate individual and network-level factors associated with HCV positivity among PWUD in a rural setting.
- To identify correlates of HCV infection to inform targeted intervention strategies.
- To explore the relationship between social network connectedness and HCV positivity.
Main Methods:
- Survey data collected from 302 PWUD in the Federal Delta Regional Authority (DRA) region of Illinois.
- HCV positivity determined by self-report as the primary outcome.
- Analysis of individual characteristics (demographics, drug use, service utilization) and social network connections.
Main Results:
- HCV positivity was associated with injection drug use, overdose history, and prior substance use treatment.
- Social network connectedness, including referral chains, did not correlate with HCV positivity rates.
- Isolated individuals showed similar HCV positivity rates compared to those with social connections.
Conclusions:
- Rural PWUD networks are diverse regarding HCV status and other characteristics.
- Peer champion-led interventions show promise for enhancing access to risk mitigation services.
- Targeted strategies are needed to address HCV in rural PWUD populations, leveraging existing social connections.
Related Concept Videos
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
Hepatic Drug Excretion: Influencing Factors
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
